This guideline covers immunotherapy for the treatment of esophageal, GE junction, gastric, duodenal and distal small bowel, pancreaticobiliary, colorectal, and anal cancer
LUNGevity has developed a comprehensive series of materials for lung cancer patients and their caregivers, focused on understanding how lung cancer develops, how it can be diagnosed, and treatment options. Whether you or someone you care about has been diagnosed with lung cancer, or is concerned...
2 attachments
See matching library entry files - "LUNGevity - Small Cell Lung Ca...
Recombinant IL-2, IL-12, and IL-15 superagonist tagged with a naturally phosphorylated peptide motif (called alum-binding protein (ABP)) were robustly and consistently phosphorylated when purified from Fam20C kinase-expressing HEK293-F cells. ABP-tagged cytokines remained absorbed on alum for more than 2 weeks in vitro in the presence of mouse serum and largely retained functional bioactivity
Small cell lung cancer (SCLC) accounts for about 15% of all lung cancers
From the Society for Immunotherapy of Cancer (SITC), this video provides an overview of the building blocks of the immune system and immunotherapy. The video also highlights recent FDA approved immunotherapy treatments and potential side effects, and the importance of clinical trials. #2016 ...
LUNGevity sat down with Patrick Forde, MD (MB, BCH), Associate Professor of Oncology at the Johns Hopkins School of Medicine, to discuss the results of the PACIFIC trial and what it means for the lung cancer survivor community. Dr. Forde is an expert on immunotherapies for lung cancer and has...
Created by SITC in 2014, the video provides patients with easy to understand and unbiased information on how cancer immunotherapy works, as well as an informative discussion regarding cancer immunotherapy clinical trials for patients with NSCLC. #PrimaryCarePhysician #2014 #PatientAdvocate...
Join leading experts in cancer immunotherapy for the SITC Cancer Immunotherapy Guidelines - Non-Small Cell Lung Cancer (NSCLC) Webinar. This FREE CME-, CNE-, CPE-certified webinar is a chance for clinicians, pharmacists, PAs, NPs, and RNs to learn about the recommendations from the recently published guideline, The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of non-small cell lung cancer (NSCLC)
09-13-2018 | 13:00 - 14:00 ET
Immunotherapy in Non-Small Cell Lung Cancer: Answering Clinically Relevant Questions Sunday, June 5, 2016 Sheraton Grand Chicago • Chicago, Illinois Presented by prIME Oncology in collaboration with the Society for Immunotherapy of Cancer This satellite symposium, which was held during the 2016 ASCO Annual Meeting, presented recent findings from clinical trials investigating immunotherapeutic agents in newly diagnosed non-small cell lung cancer (NSCLC)
06-05-2016 | 18:00 - 20:30 CT Chicago, IL
Join
Renew
Member Directory
My Profile
Email Sign-up
Volunteer
Support SITC
Contact Us